Skip to content

Study on the application value of rubiprosterone in bowel preparation for colonoscopy in patients with constipation

Study on the application value of rubiprosterone in bowel preparation for colonoscopy in patients with constipation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092647
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-11-25
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation

Interventions

B group:Take 1 rubiprostol soft capsule in the morning and evening 2 days before the examination

Sponsors

Hangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) 18 ~ 75 years old, male and female; (2) To undergo diagnostic, screening or monitoring colonoscopy; (3) Patients with chronic constipation; (4) Signed written informed consent;

Exclusion criteria

Exclusion criteria: Have severe heart, brain, lung, kidney complications or a history of acute myocardial infarction within six months; History of abdominal or pelvic surgery; Pregnant and lactating women; Risk factors for bowel preparation such as BMI > 28, BMI < 18.5, inflammatory bowel disease, or intestinal obstruction; Abnormal clotting function or taking antiplatelet or anticoagulant drugs within 7 days; Stool Bristol score 7 (watery, no solid mass), considering diarrhea; Participated in other interventional clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
Intestinal preparation quality;

Secondary

MeasureTime frame
Polyp detection rate;Detection rate of adenoma;Cecal endoscopy rate;Colonoscopy operation time;adverse reaction;Drug compliance;Intestinal preparation completion rate;satisfaction ;

Countries

China

Contacts

Public ContactYang Jianfeng

Hangzhou First People's Hospital

yjf-1976@163.com+86 134 5413 2186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026